ClinicalTrials.govpublic full text
Effect of Infusion Timing on Pathologic Response to Neoadjuvant Immunotherapy in Resectable Non-Small Cell Lung Cancer
resectable stage ii-iii non-small cell lung cancer (nsclc)
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 369822
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.